We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
EKF Diagnostics Holdings PLC | AQSE:EKF.GB | Aquis Stock Exchange | Ordinary Share | GB0031509804 | Ordinary Shares 1p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.605 | 2.20% | 28.105 | 25.00 | 30.00 | 28.105 | 27.50 | 27.50 | 8,737 | 09:09:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEKF
RNS Number : 1289K
EKF Diagnostics Holdings PLC
19 September 2016
EKF Diagnostics Holdings plc
("EKF", the "Company")
Appointment of Joint Broker
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces the appointment of N+1 Singer as Joint Broker to the Company, alongside Panmure Gordon, with immediate effect. Panmure Gordon remains Nominated Adviser to the Company.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com Christopher Mills, Non-Executive Tel: 029 2071 0570 Chairman Julian Baines, CEO Richard Evans, FD & COO Panmure Gordon (UK) Limited Tel: 020 7886 2500 (NOMAD & Joint Broker) Freddy Crossley / Peter Steel (Corporate Finance) N+1 Singer (Joint Broker) Tel: 020 7496 3000 Alex Price / Alex Laughton-Scott Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPDMGMLVVLGVZM
(END) Dow Jones Newswires
September 19, 2016 02:01 ET (06:01 GMT)
1 Year EKF Diagnostics Chart |
1 Month EKF Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions